Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference
December 05, 2022 07:30 ET
|
Organogenesis Holdings Inc.
CANTON, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Jeune Aesthetics to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech/Diagnostic Conference
December 05, 2022 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) today announced that the company will...
STRATA Skin Sciences to Participate at Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
December 02, 2022 08:00 ET
|
STRATA Skin Sciences, Inc.
HORSHAM, Pa., Dec. 02, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for...
VYNE Therapeutics to Participate in Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
December 02, 2022 08:00 ET
|
VYNE Therapeutics Inc.
BRIDGEWATER, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and...
Valitor Announces Presentation on Novel Anti-VEGF Antibody Conjugate and Multivalent Polymer Technology Platform at Upcoming Ophthalmology Innovation Source (OIS) Summit
December 01, 2022 16:00 ET
|
Valitor, Inc.
BERKELEY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that its president and chief scientific...
Anti-Retroviral Drugs Market is expected to generate a revenue of USD 45.50 Billion by 2030, Globally, at 6.70% CAGR: Verified Market Research®
December 01, 2022 09:14 ET
|
Verified Market Research
Jersey City, New Jersey, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Anti-Retroviral Drugs Market” By Type (Protease Inhibitors, Non-Nucleoside Reverse...
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
December 01, 2022 09:00 ET
|
Novan, Inc.
– Paula Brown Stafford, President and Chief Executive Officer of Novan to participate in a live moderated panel discussion on Thursday, December 8th at 11:00 AM ET – DURHAM, N.C., Dec. 01, 2022 ...
RVL Pharmaceuticals plc to Present at the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference
December 01, 2022 08:57 ET
|
RVL Pharmaceuticals plc
BRIDGEWATER, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that Brian Markison, Chief...
eMagin Corporation to Exhibit at FLORetina ICOOR 2022 Conference
December 01, 2022 08:30 ET
|
eMagin Corporation
HOPEWELL JUNCTION, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) -- eMagin Corporation (NYSE American: EMAN), a leader in the development, design, and manufacture of high-resolution OLED microdisplays for...
Outlook Therapeutics® to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
December 01, 2022 08:05 ET
|
Outlook Therapeutics, Inc.
ISELIN, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of...